Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction

Abstract Metabolic reprogramming is a hallmark of the immune cells in response to inflammatory stimuli. This metabolic process involves a switch from oxidative phosphorylation (OXPHOS) to glycolysis or alterations in other metabolic pathways. However, most of the experimental findings have been acqu...

Full description

Bibliographic Details
Main Authors: Angélica María Sabogal-Guáqueta, Alejandro Marmolejo-Garza, Marina Trombetta-Lima, Asmaa Oun, Jasmijn Hunneman, Tingting Chen, Jari Koistinaho, Sarka Lehtonen, Arjan Kortholt, Justina C. Wolters, Barbara M. Bakker, Bart J. L. Eggen, Erik Boddeke, Amalia Dolga
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-42096-7
_version_ 1797558239093587968
author Angélica María Sabogal-Guáqueta
Alejandro Marmolejo-Garza
Marina Trombetta-Lima
Asmaa Oun
Jasmijn Hunneman
Tingting Chen
Jari Koistinaho
Sarka Lehtonen
Arjan Kortholt
Justina C. Wolters
Barbara M. Bakker
Bart J. L. Eggen
Erik Boddeke
Amalia Dolga
author_facet Angélica María Sabogal-Guáqueta
Alejandro Marmolejo-Garza
Marina Trombetta-Lima
Asmaa Oun
Jasmijn Hunneman
Tingting Chen
Jari Koistinaho
Sarka Lehtonen
Arjan Kortholt
Justina C. Wolters
Barbara M. Bakker
Bart J. L. Eggen
Erik Boddeke
Amalia Dolga
author_sort Angélica María Sabogal-Guáqueta
collection DOAJ
description Abstract Metabolic reprogramming is a hallmark of the immune cells in response to inflammatory stimuli. This metabolic process involves a switch from oxidative phosphorylation (OXPHOS) to glycolysis or alterations in other metabolic pathways. However, most of the experimental findings have been acquired in murine immune cells, and little is known about the metabolic reprogramming of human microglia. In this study, we investigate the transcriptomic, proteomic, and metabolic profiles of mouse and iPSC-derived human microglia challenged with the TLR4 agonist LPS. We demonstrate that both species display a metabolic shift and an overall increased glycolytic gene signature in response to LPS treatment. The metabolic reprogramming is characterized by the upregulation of hexokinases in mouse microglia and phosphofructokinases in human microglia. This study provides a direct comparison of metabolism between mouse and human microglia, highlighting the species-specific pathways involved in immunometabolism and the importance of considering these differences in translational research.
first_indexed 2024-03-10T17:28:33Z
format Article
id doaj.art-84b22256347c40f5852d44e2ee2ceacc
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-10T17:28:33Z
publishDate 2023-10-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-84b22256347c40f5852d44e2ee2ceacc2023-11-20T10:06:07ZengNature PortfolioNature Communications2041-17232023-10-0114112410.1038/s41467-023-42096-7Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway inductionAngélica María Sabogal-Guáqueta0Alejandro Marmolejo-Garza1Marina Trombetta-Lima2Asmaa Oun3Jasmijn Hunneman4Tingting Chen5Jari Koistinaho6Sarka Lehtonen7Arjan Kortholt8Justina C. Wolters9Barbara M. Bakker10Bart J. L. Eggen11Erik Boddeke12Amalia Dolga13Department of Molecular Pharmacology, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Behavioral and Cognitive Neurosciences (BCN), University of GroningenDepartment of Molecular Pharmacology, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Behavioral and Cognitive Neurosciences (BCN), University of GroningenDepartment of Molecular Pharmacology, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Behavioral and Cognitive Neurosciences (BCN), University of GroningenDepartment of Molecular Pharmacology, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Behavioral and Cognitive Neurosciences (BCN), University of GroningenDepartment of Molecular Pharmacology, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Behavioral and Cognitive Neurosciences (BCN), University of GroningenDepartment of Molecular Pharmacology, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Behavioral and Cognitive Neurosciences (BCN), University of GroningenA.I. Virtanen Institute for Molecular Sciences, University of Eastern FinlandA.I. Virtanen Institute for Molecular Sciences, University of Eastern FinlandDepartment of Cell Biochemistry, University of GroningenLaboratory of Pediatrics, Section Systems Medicine of Metabolism and Signaling, Faculty of Medical Sciences, University of Groningen, University Medical Center GroningenLaboratory of Pediatrics, Section Systems Medicine of Metabolism and Signaling, Faculty of Medical Sciences, University of Groningen, University Medical Center GroningenDepartment of Biomedical Sciences of Cells & Systems, section Molecular Neurobiology, Faculty of Medical Sciences, University of Groningen, University Medical Center GroningenDepartment of Biomedical Sciences of Cells & Systems, section Molecular Neurobiology, Faculty of Medical Sciences, University of Groningen, University Medical Center GroningenDepartment of Molecular Pharmacology, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Behavioral and Cognitive Neurosciences (BCN), University of GroningenAbstract Metabolic reprogramming is a hallmark of the immune cells in response to inflammatory stimuli. This metabolic process involves a switch from oxidative phosphorylation (OXPHOS) to glycolysis or alterations in other metabolic pathways. However, most of the experimental findings have been acquired in murine immune cells, and little is known about the metabolic reprogramming of human microglia. In this study, we investigate the transcriptomic, proteomic, and metabolic profiles of mouse and iPSC-derived human microglia challenged with the TLR4 agonist LPS. We demonstrate that both species display a metabolic shift and an overall increased glycolytic gene signature in response to LPS treatment. The metabolic reprogramming is characterized by the upregulation of hexokinases in mouse microglia and phosphofructokinases in human microglia. This study provides a direct comparison of metabolism between mouse and human microglia, highlighting the species-specific pathways involved in immunometabolism and the importance of considering these differences in translational research.https://doi.org/10.1038/s41467-023-42096-7
spellingShingle Angélica María Sabogal-Guáqueta
Alejandro Marmolejo-Garza
Marina Trombetta-Lima
Asmaa Oun
Jasmijn Hunneman
Tingting Chen
Jari Koistinaho
Sarka Lehtonen
Arjan Kortholt
Justina C. Wolters
Barbara M. Bakker
Bart J. L. Eggen
Erik Boddeke
Amalia Dolga
Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
Nature Communications
title Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
title_full Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
title_fullStr Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
title_full_unstemmed Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
title_short Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
title_sort species specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
url https://doi.org/10.1038/s41467-023-42096-7
work_keys_str_mv AT angelicamariasabogalguaqueta speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT alejandromarmolejogarza speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT marinatrombettalima speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT asmaaoun speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT jasmijnhunneman speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT tingtingchen speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT jarikoistinaho speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT sarkalehtonen speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT arjankortholt speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT justinacwolters speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT barbarambakker speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT bartjleggen speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT erikboddeke speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction
AT amaliadolga speciesspecificmetabolicreprogramminginhumanandmousemicrogliaduringinflammatorypathwayinduction